210 related articles for article (PubMed ID: 20406107)
41. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Dam HQ; Kim SM; Lin HC; Intenzo CM
Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
[TBL] [Abstract][Full Text] [Related]
42. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome.
Logue JP; Tsang RW; Brierley JD; Simpson WJ
Br J Radiol; 1994 Nov; 67(803):1127-31. PubMed ID: 7820407
[TBL] [Abstract][Full Text] [Related]
43. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
44. Diffuse 131I lung uptake in bronchiectasis: a potential pitfall in the follow-up of differentiated thyroid carcinoma.
Triggiani V; Moschetta M; Giagulli VA; Licchelli B; Guastamacchia E
Thyroid; 2012 Dec; 22(12):1287-90. PubMed ID: 23067330
[TBL] [Abstract][Full Text] [Related]
45. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
46. Radioiodine uptake in the head and neck.
Bakheet SM; Hammami MM; Powe J; Larsson S
Endocr Pract; 2000; 6(1):37-41. PubMed ID: 11419926
[TBL] [Abstract][Full Text] [Related]
47. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
48. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
49. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
50. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
51. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
52. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
Mazzaferri EL; Kloos RT
J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
[TBL] [Abstract][Full Text] [Related]
53. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
Ma C; Xie J; Kuang A
J Nucl Med; 2005 Jul; 46(7):1164-70. PubMed ID: 16000286
[TBL] [Abstract][Full Text] [Related]
54. Follow-up of differentiated thyroid cancer.
Pacini F
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
[TBL] [Abstract][Full Text] [Related]
55. Iodine concentration by the thymus in thyroid carcinoma.
Vermiglio F; Baudin E; Travagli JP; Caillou B; Fragu P; Ricard M; Schlumberger M
J Nucl Med; 1996 Nov; 37(11):1830-1. PubMed ID: 8917186
[TBL] [Abstract][Full Text] [Related]
56. [Dermoid cyst of the ovary. False positive diagnosis in iodine 131 scintigraphy of differentiated thyroid cancers].
Rudoni S; Toubeau M; Vaillant G; Arnould L; Vergès B; Brun JM; Brunotte F
Presse Med; 1998 Sep; 27(27):1379-81. PubMed ID: 9793053
[TBL] [Abstract][Full Text] [Related]
57. International Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer.
Kraft O; Reznák I
Nucl Med Rev Cent East Eur; 2006; 9(1):84-8. PubMed ID: 16791814
[TBL] [Abstract][Full Text] [Related]
58. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
[TBL] [Abstract][Full Text] [Related]
59. Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I.
Huić D; Medvedec M; Dodig D; Popović S; Ivancević D; Pavlinovic Z; Zuvic M
Nucl Med Commun; 1996 Oct; 17(10):839-42. PubMed ID: 8951903
[TBL] [Abstract][Full Text] [Related]
60. False-positive radioiodine uptake in a functional ovarian cyst in a patient treated with total thyroidectomy for papillary cancer.
Jang HY; Kim BH; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
Intern Med; 2013; 52(20):2321-3. PubMed ID: 24126393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
